Proteinuria in Transplant Patients Associated With Sirolimus

Transplantation Proceedings

Volumn 39, Issue 2, 2007, Pages 449-452

  Franco, A F V ^a   Martini, D ^b   Abensur, H ^b   Noronha, I L ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; ARTICLE; DRUG WITHDRAWAL; EDEMA; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PRIORITY JOURNAL; PROTEINURIA;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; PROTEINURIA; SIROLIMUS;

EID: 33847706913     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.01.038     Document Type: Article

References (18)

1. Egidi M.F., Cowan P.A., Nasser A., et al. Conversion to sirolimus in solid organ transplantation: a single-center experience. Transplant Proc 35 (2003) 131S
2. Watson J.E., Firth J., Williams P.F., et al. A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation. Am J Transplant 5 (2005) 2496
3. Bumbea V., Kamar N., Ribes D., et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin to sirolimus. Nephrol Dial Transplant 20 (2005) 2517
4. Peddi V.R., Jensik S., Pescovitz M., et al. An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Clin Transplant 19 (2005) 130
5. Almeida M., Martins L.S., Figueiredo M.J., et al. Conversion to sirolimus in a population of kidney and kidney-pancreas transplant recipients. Transplant Proc 37 (2005) 2777
6. Nungaray N., Arriola M., Gutierrez M.J., et al. Rapamycin at six years can exhibit normal renal function without proteinuria or neoplasia after renal transplantation. A single-center experience. Transplant Proc 37 (2005) 3727
7. Dervaux T., Caillard S., Meyer C., et al. Is sirolimus responsible for proteinuria?. Transplant Proc 37 (2005) 2828
8. Ruiz J.C., Diekmann F., Campistol J.M., et al. Evolution of proteinuria after conversion from calcineurin inhibitors (CNi) to sirolimus (SRL) in renal transplant patients: a multicenter study. Transplant Proc 37 (2005) 3833
9. Letavernier E., Peraldi M., Pariente A., et al. Proteinuria following a switch from calcineurin inhibitors to sirolimus. Transplantation 80 (2005) 1198
10. Saurina A., Campistol J.M., Piera C., et al. Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria. Nephrol Dial Transplant 21 (2006) 488
11. Boratynska M., Banasik M., Watorek E., et al. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients. Transplant Proc 38 (2006) 101
12. Fervenza F.C., Fitzpatrick P.M., Mertz J., et al. Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies. Nephrol Dial Transplant 19 (2004) 1288
13. Dittrich E., Schmaldienst S., Soleiman A., et al. Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy. Transplant Int 17 (2004) 215
14. Morelon E., and Kreis H. Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience. Transplant Proc 35 (2003) 52S
15. Sennesael J.J., Bosmans J.L., Bogers J.P., et al. Conversion from cyclosporine to sirolimus in stable renal transplant recipients. Transplantation 80 (2005) 1578
16. van der Akker J.M., Wetzels J.F.M., and Hoitsma A.J. Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients. Kidney Int 70 (2006) 1355
17. Senior P.A., Paty B.W., Cockfield S.M., et al. Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increases tacrolimus dosing. Am J Tranplant 5 (2005) 2318
18. Straathof-Galema L., Wetzels J.F., Dijkman H.B., et al. Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism. Am J Transplant 6 (2006) 429